Phoenix, AZ, United States of America

Wesley Giron



 

Average Co-Inventor Count = 6.1

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2016-2018

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Wesley Giron: Innovator in Sublingual Spray Formulations

Introduction

Wesley Giron is a notable inventor based in Phoenix, AZ, who has made significant contributions to the field of pharmaceutical formulations. With a total of three patents to his name, Giron has focused on developing innovative solutions for treating male sexual dysfunction and pulmonary arterial hypertension.

Latest Patents

Giron's latest patents include sublingual spray formulations containing sildenafil. These inventions are directed towards methods of treating male sexual dysfunction or pulmonary arterial hypertension by administering these formulations to patients in need of such treatments. The sublingual spray offers a novel approach to delivering sildenafil, enhancing its effectiveness and patient compliance.

Career Highlights

Wesley Giron is currently associated with Insys Development Company, Inc., where he continues to work on groundbreaking pharmaceutical innovations. His expertise in formulation development has positioned him as a key player in the industry, contributing to advancements that improve patient outcomes.

Collaborations

Giron collaborates with talented professionals such as Kiran Amancha and Venkat R Goskonda, who share his commitment to innovation in the pharmaceutical sector. Together, they work towards developing effective treatment options that address critical health issues.

Conclusion

Wesley Giron stands out as an influential inventor in the realm of sublingual spray formulations, with a focus on improving treatments for male sexual dysfunction and pulmonary arterial hypertension. His work at Insys Development Company, Inc. and his collaborations with fellow innovators highlight his dedication to advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…